The trademark application SIDERA was filed by Sidera Bio ApS, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on October 30, 2024, and still open for oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 9 with Downloadable or recorded computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds, specifically in the field of cardiometabolic and central nervous system -CNS- diseases.
The mark was filed in class 42 with following description of goods:
Research and development in the pharmaceutical and biotechnology fields
Research and development of AI& Machine learning based platform to identify targets for therapeutic development, specifically in the field of cardiometabolic and central nervous system -CNS- diseases
Providing online non-downloadable project management and planning software in the field of pharmaceutical and biotechnology research and development
Modulation for the treatment of cardiometabolic and central nervous system -CNS- diseases.